3-(2-Bromo-eth-yl)-5,5-di-phenyl-imidazolidine-2,4-dione

Walid Guerrab; Abderrazzak El Moutaouakil Ala Allah; Abdulsalam Alsubari; Joel T Mague; Youssef Ramli

doi:10.1107/S2414314623000603

3-(2-Bromo-eth-yl)-5,5-di-phenyl-imidazolidine-2,4-dione

IUCrdata. 2023 Jan 26;8(Pt 1):x230060. doi: 10.1107/S2414314623000603. eCollection 2023 Jan.

Authors

Walid Guerrab¹, Abderrazzak El Moutaouakil Ala Allah¹, Abdulsalam Alsubari², Joel T Mague³, Youssef Ramli¹

Affiliations

¹ Laboratory of Medicinal Chemistry, Drug Sciences Research Center, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Morocco.
² Laboratory of Medicinal Chemistry, Faculty of Clinical Pharmacy, 21 September University, Yemen.
³ Department of Chemistry, Tulane University, New Orleans, LA 70118, USA.

Abstract

The imidazolidine ring in the title mol-ecule, C₁₇H₁₅BrN₂O₂, is slightly ruffled [r.m.s. deviation = 0.0192 Å], while the attached phenyl rings at the C atom at the position between the amine and carbonyl centres are rotated well out of its mean plane [dihedral angles with the imidazolidine ring = 63.60 (8) and 76.4 (1)°]. In the crystal, a three-dimensional network features N-H⋯O and C-H⋯O hydrogen bonds together with C-H⋯π(ring) inter-actions.

Keywords: C—H⋯π(ring) interaction; crystal structure; hydrogen bond; imidazolidenedione.

Grants and funding

JTM thanks Tulane University for support of the Tulane Crystallography Laboratory.